Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
The Journal of Experimental Medicine
|
July 7, 1998
B7-1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28
F Fallarino, P E Fields, T F Gajewski
Journal of Immunology (Baltimore, Md. : 1950)
|
October 25, 2000
Cutting edge: TGF-beta inhibits Th type 2 development through inhibition of GATA-3 expression
L Gorelik, P E Fields, R A Flavell
Journal of Immunology (Baltimore, Md. : 1950)
|
January 15, 1992
Metabolic requirements for macrophage presentation of Listeria monocytogenes to immune CD8 cells
M L Brown, P E Fields, R J Kurlander
Science (New York, N.Y.)
|
March 1, 1996
Blocked Ras activation in anergic CD4+ T cells
P E Fields, T F Gajewski, F W Fitch
Journal of Immunology (Baltimore, Md. : 1950)
|
May 22, 2001
A transcriptional block in the IL-2 promoter at the -150 AP-1 site in effector CD8+ T cells
R J Finch, P E Fields, P D Greenberg
Immunity
|
May 5, 2001
Regulation of IL-4 gene expression by distal regulatory elements and GATA-3 at the chromatin level
G R Lee, P E Fields, R A Flavell
Journal of Immunology (Baltimore, Md. : 1950)
|
March 10, 2001
Absence of CTLA-4 lowers the activation threshold of primed CD8+ TCR-transgenic T cells: lack of correlation with Src homology domain 2-containing protein tyrosine phosphatase
T F Gajewski, F Fallarino, P E Fields, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 15, 1997
CD28 costimulation promotes the production of Th2 cytokines
I C Rulifson, A I Sperling, P E Fields, et al.
The Journal of Tropical Medicine and Hygiene
|
February 1, 1981
Histoplasmosis in the eastern Caribbean: a preliminary survey of the incidence of the infection
R J Hay, H S White, P E Fields, et al.
The Journal of Experimental Medicine
|
July 1, 1993
Major histocompatibility complex class II-restricted presentation of an internally synthesized antigen displays cell-type variability and segregates from the exogenous class II and endogenous class I presentation pathways
G E Loss, C G Elias, P E Fields, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
The Journal of Experimental Medicine
|
July 7, 1998
B7-1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28
F Fallarino, P E Fields, T F Gajewski
Journal of Immunology (Baltimore, Md. : 1950)
|
October 25, 2000
Cutting edge: TGF-beta inhibits Th type 2 development through inhibition of GATA-3 expression
L Gorelik, P E Fields, R A Flavell
Journal of Immunology (Baltimore, Md. : 1950)
|
January 15, 1992
Metabolic requirements for macrophage presentation of Listeria monocytogenes to immune CD8 cells
M L Brown, P E Fields, R J Kurlander
Science (New York, N.Y.)
|
March 1, 1996
Blocked Ras activation in anergic CD4+ T cells
P E Fields, T F Gajewski, F W Fitch
Journal of Immunology (Baltimore, Md. : 1950)
|
May 22, 2001
A transcriptional block in the IL-2 promoter at the -150 AP-1 site in effector CD8+ T cells
R J Finch, P E Fields, P D Greenberg
Immunity
|
May 5, 2001
Regulation of IL-4 gene expression by distal regulatory elements and GATA-3 at the chromatin level
G R Lee, P E Fields, R A Flavell
Journal of Immunology (Baltimore, Md. : 1950)
|
March 10, 2001
Absence of CTLA-4 lowers the activation threshold of primed CD8+ TCR-transgenic T cells: lack of correlation with Src homology domain 2-containing protein tyrosine phosphatase
T F Gajewski, F Fallarino, P E Fields, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 15, 1997
CD28 costimulation promotes the production of Th2 cytokines
I C Rulifson, A I Sperling, P E Fields, et al.
The Journal of Tropical Medicine and Hygiene
|
February 1, 1981
Histoplasmosis in the eastern Caribbean: a preliminary survey of the incidence of the infection
R J Hay, H S White, P E Fields, et al.
The Journal of Experimental Medicine
|
July 1, 1993
Major histocompatibility complex class II-restricted presentation of an internally synthesized antigen displays cell-type variability and segregates from the exogenous class II and endogenous class I presentation pathways
G E Loss, C G Elias, P E Fields, et al.
Page
of 2